Fexofenadine was developed by Hoechst Marion Roussel (now part of Aventis) and approved by the Food and Drug Administration (FDA) in 1996. Since that time, it has achieved blockbuster drug status with global sales of $1.87B USD in 2004 (with $1.49B USD coming from the United States).
October 7, 2009
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URL
Sorry, the comment form is closed at this time.
History Fexofenadine - Allegra
Fexofenadine was developed by Hoechst Marion Roussel (now part of Aventis) and approved by the Food and Drug Administration (FDA) in 1996. Since that time, it has achieved blockbuster drug status with global sales of $1.87B USD in 2004 (with $1.49B USD coming from the United States).
No Comments
No comments yet.
RSS feed for comments on this post. TrackBack URL
Sorry, the comment form is closed at this time.